Dorevitch Pathology

Dorevitch Pathology, established in 1970, is a leading provider of pathology diagnostics and testing services in Victoria, Australia. The company operates an extensive network of over 400 collection centers, ensuring broad accessibility for patients and clinicians. It leverages advanced laboratory technology to deliver accurate and timely results for a wide spectrum of routine and specialized tests. Dorevitch Pathology's service portfolio extends to commercial offerings, including drug and alcohol testing, employee wellness screenings, and crucial support for research initiatives and clinical trials. This comprehensive approach underscores its commitment to advancing healthcare diagnostics and patient outcomes.

The company's operational scale is significant, with a revenue of $156.8M and an employee range of 500-1,000 individuals. Its presence spans 35 locations, facilitating widespread service delivery. Dorevitch Pathology is dedicated to patient-centric care, offering resources such as telehealth services and educational support for healthcare professionals, thereby enhancing the overall healthcare ecosystem. Understanding the human element behind its operations is key, and one can learn more by Meet Dorevitch Pathology's team. The company's commitment to quality and efficiency in diagnostic services positions it as a key player in the Australian healthcare sector.

In the competitive landscape of medical testing, Dorevitch Pathology competes with entities like Laverty Pathology, Australian Clinical Labs, and QML Pathology. Its strategic focus on both patient and clinician services, coupled with its broad diagnostic capabilities, allows it to maintain a strong market position. The company's product offerings include a variety of testing services, pathology, health testing, occupational health assessments, and specimen collection. Dorevitch Pathology's integratedView more...